-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Pharmaceutical Stock Market] On August 18, the National Medical Insurance Administration issued an announcement to solicit public opinions on the "Notice on the Special Treatment of Oral Implantation Medical Service Fees and Consumables Prices (Draft for Comment)"
.
The industry believes that this means that the pace of centralized dental implant collection is further approaching
.
Due to the high price of dental implants and the non-standard charges, patients have a heavy burden on the cost of dental implants.
Therefore, the centralized procurement of dental implants has attracted the attention of the industry, and its promotion work has been in progress
.
As early as January, there was news that China would gradually expand the coverage of centralized procurement of high-value medical consumables, and conduct centralized procurement at the national and provincial levels for orthopedic consumables, drug balloons, and dental implants that are of great concern to the public.
For the first time, it was mentioned that dental implants should be included in the centralized procurement.
Subsequently, some places have actively explored the pilot work of limiting the price of dental implants
.
In May 2022, nine ministries and commissions jointly issued the "Key Points of Correcting Unhealthy Practices in the Field of Pharmaceutical Purchase and Sales and Medical Services in 2022", requiring standardization of dental medical services and charges for consumables, and for carrying out dental implant services, but not participating in the inter-provincial alliance of dental implant consumables Procurement of medical institutions to carry out key inspections
.
In early August, the National Medical Insurance Bureau also required all provinces to carry out "investigation and registration of dental implant charges and medical service prices", which included the prices of implant systems and dental crown products
.
This action is also regarded in the industry as a preparatory action for dental implant collection
.
This consultation draft includes 12 articles in four parts, focusing on standardizing the charging method of oral implants, integrating the corresponding medical service price items such as implant placement and crown placement; doing price regulation around the whole process of dental implants, reducing public medical care The high prices of institutional dental implant medical services and the strengthening of the supervision and guidance of dental implant prices in private medical institutions can be seen to point to the inflated prices of dental implants
.
Dental implants are expensive in materials and technology.
In this regard, the document mentions that it is necessary to standardize the charging methods for dental implant medical services and consumables
.
Orderly promote the "separation of technology and consumption" of dental implant medical services
.
Public medical institutions provide dental implant medical services, mainly adopting a separate pricing method of "service items + special consumables"
.
For the current situation that consumables are combined in the price of medical service items, when the "separation of technology and consumption" is implemented, the project price should be reduced simultaneously in the way of deducting the average online purchase price of related consumables
.
The document also clarifies that it is necessary to adhere to the ups and downs, and to straighten out the relationship between the prices of related medical services
.
Implants, crowns, and bone grafts are mainly due to the strong feedback from the masses and the heavy cost burden
.
It is foreseeable that in addition to standardizing medical services and consumables charging methods in the implant industry, the future centralized procurement policy will expand the breadth and depth of consumables
.
Since the announcement of the dental implant price survey news, many shares have been affected
.
Among them, Tongce Medical's stock price closed down for two consecutive days from August 15th to 16th
.
On August 19, the day after the release of the consultation draft, the stock continued to fall.
As of 9:56, the stock fell by 6.
39%, with a quotation of 122.
41 yuan, a turnover of 656 million, and a turnover rate of 1.
64%
.
The 2021 financial report shows that Tongce Medical has five major business segments: implantation, orthodontics, pediatrics, restoration and large comprehensive.
Among them, the proportion of revenue from dental implants has increased, from 16% in 2020 to 17% in 2021.
The proportion of deformity, pediatrics and general business remained unchanged, while the proportion of repair decreased
.
However, in response to the issue of centralized procurement, a relevant person from Tongce Medical told the media that whether the company's products entering centralized procurement will significantly reduce profits, the question is whether there are candidates for centralized procurement products
.
In addition, based on the hierarchical attributes of customers, Tongce does not believe that the products that enter the centralized procurement will affect the company's high-end products
.
In addition to Tongce Medical, Times Angel fell about 8% in the afternoon of August 16
.
Earlier, Times Angel issued an interim profit warning
.
CITIC Securities believes that the company's 2022H1 performance is under pressure, and it is expected to resume healthy growth in the post-epidemic period
.
The demand of patients is expected to be delayed, and benign growth is expected to gradually resume in the second half of the year
.
It is worth mentioning that the stock prices of China Ceramic Materials and Meiya Optoelectronics, which are also in the dental implant industry chain, both rose slightly on August 15, with an increase of 3.
86% and 1.
65% respectively
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
The industry believes that this means that the pace of centralized dental implant collection is further approaching
.
Due to the high price of dental implants and the non-standard charges, patients have a heavy burden on the cost of dental implants.
Therefore, the centralized procurement of dental implants has attracted the attention of the industry, and its promotion work has been in progress
.
As early as January, there was news that China would gradually expand the coverage of centralized procurement of high-value medical consumables, and conduct centralized procurement at the national and provincial levels for orthopedic consumables, drug balloons, and dental implants that are of great concern to the public.
For the first time, it was mentioned that dental implants should be included in the centralized procurement.
Subsequently, some places have actively explored the pilot work of limiting the price of dental implants
.
In May 2022, nine ministries and commissions jointly issued the "Key Points of Correcting Unhealthy Practices in the Field of Pharmaceutical Purchase and Sales and Medical Services in 2022", requiring standardization of dental medical services and charges for consumables, and for carrying out dental implant services, but not participating in the inter-provincial alliance of dental implant consumables Procurement of medical institutions to carry out key inspections
.
In early August, the National Medical Insurance Bureau also required all provinces to carry out "investigation and registration of dental implant charges and medical service prices", which included the prices of implant systems and dental crown products
.
This action is also regarded in the industry as a preparatory action for dental implant collection
.
This consultation draft includes 12 articles in four parts, focusing on standardizing the charging method of oral implants, integrating the corresponding medical service price items such as implant placement and crown placement; doing price regulation around the whole process of dental implants, reducing public medical care The high prices of institutional dental implant medical services and the strengthening of the supervision and guidance of dental implant prices in private medical institutions can be seen to point to the inflated prices of dental implants
.
Dental implants are expensive in materials and technology.
In this regard, the document mentions that it is necessary to standardize the charging methods for dental implant medical services and consumables
.
Orderly promote the "separation of technology and consumption" of dental implant medical services
.
Public medical institutions provide dental implant medical services, mainly adopting a separate pricing method of "service items + special consumables"
.
For the current situation that consumables are combined in the price of medical service items, when the "separation of technology and consumption" is implemented, the project price should be reduced simultaneously in the way of deducting the average online purchase price of related consumables
.
The document also clarifies that it is necessary to adhere to the ups and downs, and to straighten out the relationship between the prices of related medical services
.
Implants, crowns, and bone grafts are mainly due to the strong feedback from the masses and the heavy cost burden
.
It is foreseeable that in addition to standardizing medical services and consumables charging methods in the implant industry, the future centralized procurement policy will expand the breadth and depth of consumables
.
Since the announcement of the dental implant price survey news, many shares have been affected
.
Among them, Tongce Medical's stock price closed down for two consecutive days from August 15th to 16th
.
On August 19, the day after the release of the consultation draft, the stock continued to fall.
As of 9:56, the stock fell by 6.
39%, with a quotation of 122.
41 yuan, a turnover of 656 million, and a turnover rate of 1.
64%
.
The 2021 financial report shows that Tongce Medical has five major business segments: implantation, orthodontics, pediatrics, restoration and large comprehensive.
Among them, the proportion of revenue from dental implants has increased, from 16% in 2020 to 17% in 2021.
The proportion of deformity, pediatrics and general business remained unchanged, while the proportion of repair decreased
.
However, in response to the issue of centralized procurement, a relevant person from Tongce Medical told the media that whether the company's products entering centralized procurement will significantly reduce profits, the question is whether there are candidates for centralized procurement products
.
In addition, based on the hierarchical attributes of customers, Tongce does not believe that the products that enter the centralized procurement will affect the company's high-end products
.
In addition to Tongce Medical, Times Angel fell about 8% in the afternoon of August 16
.
Earlier, Times Angel issued an interim profit warning
.
CITIC Securities believes that the company's 2022H1 performance is under pressure, and it is expected to resume healthy growth in the post-epidemic period
.
The demand of patients is expected to be delayed, and benign growth is expected to gradually resume in the second half of the year
.
It is worth mentioning that the stock prices of China Ceramic Materials and Meiya Optoelectronics, which are also in the dental implant industry chain, both rose slightly on August 15, with an increase of 3.
86% and 1.
65% respectively
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
